DK2297333T3 - Fremgangsmåde til rumlig adskillelse og til screening af celler - Google Patents

Fremgangsmåde til rumlig adskillelse og til screening af celler Download PDF

Info

Publication number
DK2297333T3
DK2297333T3 DK09755288.9T DK09755288T DK2297333T3 DK 2297333 T3 DK2297333 T3 DK 2297333T3 DK 09755288 T DK09755288 T DK 09755288T DK 2297333 T3 DK2297333 T3 DK 2297333T3
Authority
DK
Denmark
Prior art keywords
enzyme
cells
activity
library
enzymes
Prior art date
Application number
DK09755288.9T
Other languages
English (en)
Inventor
Kerry Love
J Christopher Love
Original Assignee
Massachusetts Inst Technology
Whitehead Biomedical Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology, Whitehead Biomedical Inst filed Critical Massachusetts Inst Technology
Application granted granted Critical
Publication of DK2297333T3 publication Critical patent/DK2297333T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/25—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/533—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving isomerase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91091—Glycosyltransferases (2.4)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Claims (16)

1. Fremgangsmåde til at gennemføre en screening af enzymer i opløsningsfase, omfattende: afsætte et bibliotek af celler på en mikroindretning, hvor mikroindretningen indeholder brønde, som rumligt adskiller cellerne i opløsning, hvor cellerne fordeles med én celle per brønd i gennemsnit, hvor en flerhed af cellerne sekrerer varianter af mindst én enzym i opløsningen; bringe de sekrerede enzymvarianter i opløsningen i kontakt med mindst ét optisk signalsubstrat; hvor enzymaktiviteten overvåges ved at detektere ændringer over tiden i et eller flere optiske signaler, som genereres af det ene eller flere optiske signalsubstrater i cellebiblioteket, hvor sådanne ændringer angiver en ønsket aktivitet af varianterne af enzymet.
2. Fremgangsmåde ifølge krav 1, hvor det optiske signal er et fluorescenssignal.
3. Fremgangsmåde ifølge krav 2, hvor enzymaktiviteten overvåges i realtid eller næsten realtid i mikroindretningen på basis af ændringer i intensiteterne af fluorescerenssignal.
4. Fremgangsmåde ifølge krav 1, hvor enzymet er udvalgt fra gruppen bestående af protease, oxidoreduktase, transferase, hydrolase, lyase, isomera-se og ligase.
5. Fremgangsmåde ifølge krav 4, hvor molekylvægten af enzymet er større end ca. 600 Da og mindre end ca. 100.000 Da.
6. Fremgangsmåde ifølge krav 1, hvor enzymaktiviteten vurderes på basis af flere parametre, der er udvalgt fra gruppen bestående af katalytisk hastighed, reaktionsspecificitet, kinetisk effektivitet og substratbindingsaffinitet.
7. Fremgangsmåde ifølge krav 6, hvor parametrene vurderes parallelt.
8. Fremgangsmåde ifølge krav 1, hvor cellerne er eukaryotiske celler.
9. Fremgangsmåde ifølge krav 8, hvor de eukaryotiske celler er gærceller.
10. Fremgangsmåde ifølge krav 1, hvor brøndene er mellem ca. 10 og ca. 100 pm i diameter.
11. Fremgangsmåde ifølge krav 1, yderligere omfattende generering af varianterne med en trin, som omfatter mutation af det gen, som koder for enzymet.
12. Fremgangsmåde ifølge krav 1, yderligere omfattende genvinding af de celler, som sekrerer en ønsket enzymvariant fra mikroindretningen.
13. Fremgangsmåde ifølge krav 12, hvor genvindingen sker ved hjælp af mi-kromanipulation med glaskapillærer.
14. Fremgangsmåde ifølge krav 13, yderligere omfattende isolering og sekvensering af DNA, som koder for den ønskede enzymvariant.
15. Fremgangsmåde ifølge krav 2, hvor enzymet er en mutation af glycosyl-transferase (GTase) eller glycosidase.
16. Fremgangsmåde ifølge krav 15, hvor GTase er i stand til at konkurrere med kemisk syntese om hurtig fremstilling i stor målestok af komplekse kulhydrater.
DK09755288.9T 2008-05-30 2009-06-01 Fremgangsmåde til rumlig adskillelse og til screening af celler DK2297333T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5737108P 2008-05-30 2008-05-30
PCT/US2009/003354 WO2009145925A1 (en) 2008-05-30 2009-06-01 Compositions and methods for spatial separation and screening of cells

Publications (1)

Publication Number Publication Date
DK2297333T3 true DK2297333T3 (da) 2015-04-07

Family

ID=41377450

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09755288.9T DK2297333T3 (da) 2008-05-30 2009-06-01 Fremgangsmåde til rumlig adskillelse og til screening af celler

Country Status (7)

Country Link
US (3) US20110124520A1 (da)
EP (1) EP2297333B1 (da)
JP (1) JP5718221B2 (da)
CN (1) CN102112624A (da)
CA (1) CA2763790C (da)
DK (1) DK2297333T3 (da)
WO (1) WO2009145925A1 (da)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8748103B2 (en) 2008-11-07 2014-06-10 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
US9365901B2 (en) 2008-11-07 2016-06-14 Adaptive Biotechnologies Corp. Monitoring immunoglobulin heavy chain evolution in B-cell acute lymphoblastic leukemia
US9506119B2 (en) 2008-11-07 2016-11-29 Adaptive Biotechnologies Corp. Method of sequence determination using sequence tags
CN104195227B (zh) 2008-11-07 2017-04-12 适应生物技术公司 通过序列分析监测状况的方法
US8691510B2 (en) 2008-11-07 2014-04-08 Sequenta, Inc. Sequence analysis of complex amplicons
US8628927B2 (en) 2008-11-07 2014-01-14 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
US9528160B2 (en) 2008-11-07 2016-12-27 Adaptive Biotechnolgies Corp. Rare clonotypes and uses thereof
US9404924B2 (en) 2008-12-04 2016-08-02 Massachusetts Institute Of Technology Method of performing one-step, single cell RT-PCR
JP5675638B2 (ja) 2008-12-04 2015-02-25 マサチューセッツ インスティテュート オブ テクノロジー アレルギー反応を診断するための方法
US8685898B2 (en) 2009-01-15 2014-04-01 Imdaptive, Inc. Adaptive immunity profiling and methods for generation of monoclonal antibodies
KR20110134386A (ko) 2009-01-21 2011-12-14 메사추세츠 인스티튜트 오브 테크놀로지 단일 세포의 세포독성을 평가하기 위한 조성물 및 방법
CA2765949C (en) 2009-06-25 2016-03-29 Fred Hutchinson Cancer Research Center Method of measuring adaptive immunity
US9043160B1 (en) 2009-11-09 2015-05-26 Sequenta, Inc. Method of determining clonotypes and clonotype profiles
US10087408B2 (en) 2010-07-07 2018-10-02 The University Of British Columbia System and method for microfluidic cell culture
US20130115606A1 (en) 2010-07-07 2013-05-09 The University Of British Columbia System and method for microfluidic cell culture
US10385475B2 (en) 2011-09-12 2019-08-20 Adaptive Biotechnologies Corp. Random array sequencing of low-complexity libraries
AU2012325791B2 (en) 2011-10-21 2018-04-05 Adaptive Biotechnologies Corporation Quantification of adaptive immune cell genomes in a complex mixture of cells
ES2683037T3 (es) 2011-12-09 2018-09-24 Adaptive Biotechnologies Corporation Diagnóstico de tumores malignos linfoides y detección de enfermedad residual mínima
US9499865B2 (en) 2011-12-13 2016-11-22 Adaptive Biotechnologies Corp. Detection and measurement of tissue-infiltrating lymphocytes
US10077478B2 (en) 2012-03-05 2018-09-18 Adaptive Biotechnologies Corp. Determining paired immune receptor chains from frequency matched subunits
SG10201507700VA (en) 2012-05-08 2015-10-29 Adaptive Biotechnologies Corp Compositions and method for measuring and calibrating amplification bias in multiplexed pcr reactions
AU2013327423B2 (en) 2012-10-01 2017-06-22 Adaptive Biotechnologies Corporation Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization
US10150996B2 (en) 2012-10-19 2018-12-11 Adaptive Biotechnologies Corp. Quantification of adaptive immune cell genomes in a complex mixture of cells
GB2511761A (en) 2013-03-11 2014-09-17 Cancer Rec Tech Ltd Methods for detecting molecules in a sample
US9708657B2 (en) 2013-07-01 2017-07-18 Adaptive Biotechnologies Corp. Method for generating clonotype profiles using sequence tags
ES2741740T3 (es) 2014-03-05 2020-02-12 Adaptive Biotechnologies Corp Métodos que usan moléculas sintéticas que contienen segmentos de nucleótidos aleatorios
JP6366053B2 (ja) * 2014-03-31 2018-08-01 国立研究開発法人農業・食品産業技術総合研究機構 標準試料製造方法
US11390921B2 (en) 2014-04-01 2022-07-19 Adaptive Biotechnologies Corporation Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs)
US10066265B2 (en) 2014-04-01 2018-09-04 Adaptive Biotechnologies Corp. Determining antigen-specific t-cells
ES2784343T3 (es) 2014-10-29 2020-09-24 Adaptive Biotechnologies Corp Detección simultánea altamente multiplexada de ácidos nucleicos que codifican heterodímeros de receptores inmunes adaptativos emparejados de muchas muestras
US10246701B2 (en) 2014-11-14 2019-04-02 Adaptive Biotechnologies Corp. Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture
CA2968543C (en) 2014-11-25 2024-04-02 Adaptive Biotechnologies Corporation Characterization of adaptive immune response to vaccination or infection using immune repertoire sequencing
CN107407638B (zh) 2014-12-03 2021-01-12 伊索普莱西斯公司 细胞分泌特征的分析和筛选
WO2016138122A1 (en) 2015-02-24 2016-09-01 Adaptive Biotechnologies Corp. Methods for diagnosing infectious disease and determining hla status using immune repertoire sequencing
WO2016149639A1 (en) 2015-03-19 2016-09-22 The Board Of Trustees Of The Leland Stanford Junior University Devices and methods for high-throughput single cell and biomolecule analysis and retrieval in a microfluidic chip
EP3277294B1 (en) 2015-04-01 2024-05-15 Adaptive Biotechnologies Corp. Method of identifying human compatible t cell receptors specific for an antigenic target
US10677793B2 (en) * 2015-04-21 2020-06-09 General Automation Lab Technologies Inc. High resolution systems, kits, apparatus, and methods using lateral flow for high throughput microbiology applications
WO2017124101A2 (en) 2016-01-15 2017-07-20 The Broad Institute Inc. Semi-permeable arrays for analyzing biological systems and methods of using same
CN105740509A (zh) * 2016-01-22 2016-07-06 河北工业大学 一种考虑脱硼的分流部分二级卷式膜元件反渗透海水淡化系统优化方法
CN109155149A (zh) * 2016-03-29 2019-01-04 瑞泽恩制药公司 遗传变体-表型分析系统和使用方法
US10428325B1 (en) 2016-09-21 2019-10-01 Adaptive Biotechnologies Corporation Identification of antigen-specific B cell receptors
CA3041109A1 (en) * 2016-10-19 2018-04-26 General Automation Lab Technologies Inc. High resolution systems, kits, apparatus, and methods for screening microorganisms and other high throughput microbiology applications
DK3538891T3 (da) 2016-11-11 2022-03-28 Isoplexis Corp Sammensætninger og fremgangsmåder til samtidig genomisk, transkriptomisk og proteomisk analyse af enkeltceller
CN110226084A (zh) 2016-11-22 2019-09-10 伊索普莱克西斯公司 用于细胞捕获的系统、装置和方法，以及其制造方法
US11085039B2 (en) 2016-12-12 2021-08-10 xCella Biosciences, Inc. Methods and systems for screening using microcapillary arrays
JP7356351B2 (ja) 2016-12-12 2023-10-04 エクセラ・バイオサイエンシーズ・インコーポレイテッド マイクロキャピラリーアレイを使用したスクリーニングのための方法およびシステム
JP7208902B2 (ja) 2016-12-30 2023-01-19 エクセラ・バイオサイエンシーズ・インコーポレイテッド マルチステージサンプル回収システム
US11254980B1 (en) 2017-11-29 2022-02-22 Adaptive Biotechnologies Corporation Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements
WO2019113457A1 (en) 2017-12-07 2019-06-13 Massachusetts Institute Of Technology Single cell analyses
JP7351290B2 (ja) * 2018-03-12 2023-09-27 ソニーグループ株式会社 細胞評価装置及び細胞評価システム
WO2020120442A2 (en) 2018-12-13 2020-06-18 Dna Script Direct oligonucleotide synthesis on cells and biomolecules
CN111041025B (zh) * 2019-12-17 2021-06-18 深圳市瑞吉生物科技有限公司 基于结合N-乙酰半乳糖胺多肽的mRNA靶向分子及其制备方法
CN111744019B (zh) 2020-07-01 2023-08-04 深圳瑞吉生物科技有限公司 基于甘露糖的mRNA靶向递送系统及其应用
WO2023133566A1 (en) * 2022-01-07 2023-07-13 The Regents Of The University Of California Systems and methods for particle mapping

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL68507A (en) * 1982-05-10 1986-01-31 Univ Bar Ilan System and methods for cell selection
US6171820B1 (en) * 1995-12-07 2001-01-09 Diversa Corporation Saturation mutagenesis in directed evolution
US6410252B1 (en) * 1995-12-22 2002-06-25 Case Western Reserve University Methods for measuring T cell cytokines
US6210910B1 (en) * 1998-03-02 2001-04-03 Trustees Of Tufts College Optical fiber biosensor array comprising cell populations confined to microcavities
US5914245A (en) 1998-04-20 1999-06-22 Kairos Scientific Inc. Solid phase enzyme kinetics screening in microcolonies
US6576478B1 (en) * 1998-07-14 2003-06-10 Zyomyx, Inc. Microdevices for high-throughput screening of biomolecules
MXPA02008386A (es) * 2000-04-05 2004-03-26 California Inst Of Techn Metodo de seleccion para el descubrimiento y evolucion dirigida en enzimas de oxigenasa.
AU2002230524A1 (en) * 2000-11-16 2002-05-27 California Institute Of Technology Apparatus and methods for conducting assays and high throughput screening
JP2005253412A (ja) * 2004-03-15 2005-09-22 Masayasu Suzuki マイクロウェルアレイチップ、その製造方法及び被検体の活性検定方法
WO2007035633A2 (en) 2005-09-16 2007-03-29 President & Fellows Of Harvard College Screening assays and methods
US7995202B2 (en) * 2006-02-13 2011-08-09 Pacific Biosciences Of California, Inc. Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources

Also Published As

Publication number Publication date
EP2297333A4 (en) 2012-03-14
EP2297333B1 (en) 2015-01-28
US20210102933A1 (en) 2021-04-08
EP2297333A1 (en) 2011-03-23
US20110124520A1 (en) 2011-05-26
JP5718221B2 (ja) 2015-05-13
JP2011521644A (ja) 2011-07-28
CA2763790C (en) 2016-11-22
CA2763790A1 (en) 2009-12-03
US20180335419A1 (en) 2018-11-22
WO2009145925A1 (en) 2009-12-03
CN102112624A (zh) 2011-06-29

Similar Documents

Publication Publication Date Title
US20210102933A1 (en) Compositions and methods for spatial separation and screening of cells
Lowe et al. Multiplex sensing of protease and kinase enzyme activity via orthogonal coupling of quantum dot–peptide conjugates
AU2002303311B2 (en) Microfermentor device and cell based screening method
Espina et al. Use of proteomic analysis to monitor responses to biological therapies
EP2823050B1 (en) Diagnostic chewing gum for pathogens
AU2002303311A1 (en) Microfermentor device and cell based screening method
US7585643B2 (en) Method for detecting kinase activity with thiol reactive fluorescent reagents
Zhang et al. Visual analysis and inhibitor screening of leucine aminopeptidase, a key virulence factor for pathogenic bacteria-associated infection
van der Heden van Noort Chemical tools to study protein ADP-ribosylation
Avilés-Reyes et al. Characterization of the pgf operon involved in the posttranslational modification of Streptococcus mutans surface proteins
WO2007071829A3 (en) Methods and means related to diseases
US20230201357A1 (en) D-dimer-specific aptamers and methods of use in diagnostics, therapeutic and theranostic purposes
Wang et al. Multi-colorful ratio fluorescent biosensing of β-glucosidase activity based on the rapidly synthetic gold nanoclusters
Wang et al. Fluorescence imaging-based methods for single-cell protein analysis
Wang et al. Discrimination of cell death types with an activatable fluorescent probe through visualizing the lysosome morphology
Agrawal et al. Click-chemistry-based free Azide versus azido sugar detection enables rapid in vivo screening of Glycosynthase activity
WO2023278699A1 (en) Viral protein specific aptamers and methods of use in diagnostics, therapeutic purposes
EP1918713A1 (en) Analysis of proteolytic processing by mass spectrometry
Xiong et al. Fluorogenic and chromogenic detection of carboxypeptidase Y with a nonpeptide-based small-molecule probe
Feng et al. Functional mass nanoprobes inserted on live cells for in situ monitoring multiple secreted enzymes with MALDI-TOF mass spectrometry
Pohl Functional proteomics for the discovery of carbohydrate-related enzyme activities
Wang et al. G‐Quadruplex‐Linked Supersandwich DNA Structure for Electrochemical Amplified Detection of Thrombin
da Silva Lectins as Biorecognition Elements in Biosensors for Clinical Applications in Cancer
WO2024020124A1 (en) Engineering dynamic dna nano-devices to amplify signal
Jiang Discovery of potent inhibitors of human β-tryptase by protein surface recognition